Doctor Mi Joo Kim
Daejeon (Korea (Republic of))
Comparison of the new oral P2Y12 inhibitor (Prasugrel/Ticagrelor) to Clopidogrel in type 2 diabetes mellitus patients with AMI
Event: ESC Congress 2016
Topic: Thrombosis and platelets
Session: Antiplatelet therapy
ESC 365 is supported by
